Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy.
about
Current and future contraceptive options for women living with HIV.Physiologically based pharmacokinetic modelling prediction of the effects of dose adjustment in drug-drug interactions between levonorgestrel contraceptive implants and efavirenz-based ART.Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasma.
P2860
Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Efavirenz decreases etonogestr ...... n with antiretroviral therapy.
@en
type
label
Efavirenz decreases etonogestr ...... n with antiretroviral therapy.
@en
prefLabel
Efavirenz decreases etonogestr ...... n with antiretroviral therapy.
@en
P2093
P2860
P1433
P1476
Efavirenz decreases etonogestr ...... n with antiretroviral therapy.
@en
P2093
Beatrice A Chen
Catherine A Chappell
Hope Mackline
Kristin M Darin
Mohammed Lamorde
Shadia Nakalema
Sharon A Riddler
Susan E Cohn
P2860
P304
P356
10.1097/QAD.0000000000001591
P407
P577
2017-07-07T00:00:00Z